The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.00
Bid: 33.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 2.00 (6.061%)
Open: 34.00
High: 34.00
Low: 34.00
Prev. Close: 34.00
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

29 Aug 2018 07:00

RNS Number : 0572Z
Mercia Technologies PLC
29 August 2018
 

For immediate release

29 August 2018

 

Mercia Technologies PLC

 

("Mercia" or the "Company")

 

Grant of Options

 

Mercia Technologies PLC (AIM: MERC), the national investment group focused on the identification, creation, funding and scaling of innovative technology businesses with high growth potential from the UK regions, announces that options (the "Options") over a total of 4,689,000 new Ordinary shares with a nominal value of 0.001p each in the capital of the Company ("Ordinary Shares") were awarded yesterday pursuant to the 2014 Mercia Company Share Option Plan at an exercise price of 30.80p per Ordinary Share (being the closing mid-market price of an Ordinary Share on 28 August 2018). The Options will, subject to the satisfaction of the performance condition, vest in three equal tranches on the third, fourth and fifth anniversary of the date of grant of the Options.

 

The Options represent, in aggregate, 1.55% of the existing Ordinary share capital of the Company and have been issued to a number of employees of the Company, including all three Executive Directors and three further persons discharging managerial responsibilities ("PDMRs"). 

 

Following these grants, the Company has a total of 14,851,000 unvested options pursuant to the 2014 Mercia Company Share Option Plan, equating to approximately 4.90% of the existing issued Ordinary share capital of the Company.

 

Following the grant of these Options, PDMRs hold the following Ordinary Shares and options:

 

Name

Role

Grant of Options over Ordinary Shares

Total number of options over Ordinary Shares

Interest in existing issued Ordinary Shares

Dr. Mark Payton

Chief Executive Officer

400,000

2,200,000

6,655,472

Martin Glanfield

Chief Financial Officer

400,000

2,200,000

293,369

Julian Viggars

Chief Investment Officer

1,200,000

1,600,000

424,325*

Peter Dines

PDMR

600,000

600,000

45,551

John Simpson

PDMR

200,000

450,000

754,997

Ceri Bailey

PDMR

100,000

100,000

21,739

*Including 75,000 Ordinary Shares held by Mrs Emma Viggars.

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by person discharging managerial responsibilities.

 

1

Details of the persons discharging managerial responsibilities/person closely associated

a)

Name

(i) Dr. Mark Payton - Chief Executive Officer

(ii) Martin Glanfield - Chief Financial Officer

(iii) Julian Viggars - Chief Investment Officer

(iv) Peter Dines - PDMR

(v) John Simpson - PDMR

(vi) Ceri Bailey - PDMR

2

Reason for the notification

a)

Position/status

Executive Directors and PDMRs of the Company

b)

Initial Notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mercia Technologies PLC

b)

Legal Entity Identifier

213800A1Q4CF57NECG66

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.001 pence each

 

 

 

ISIN: GB00BSL71W47

b)

Nature of the transaction

Grant of options

c)

Currency

GBP

d)

Price(s) and volume(s)

Exercise Price

No. of shares

£0.3080

(i) 400,000

£0.3080

(ii) 400,000

£0.3080

(iii) 1,200,000

£0.3080

(iv) 600,000

£0.3080

(v) 200,000

£0.3080

(vi) 100,000

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

N/A - single transactions

f)

Date of the transaction

28 August 2018

g)

Place of the transaction

Outside a trading venue

 

 

 

For further information, please contact:

Mercia Technologies PLC

Mark Payton, Chief Executive Officer

Martin Glanfield, Chief Financial Officer

www.merciatech.co.uk

 

+44 (0)330 223 1430

 

Cenkos Securities plc

Stephen Keys (NOMAD and Joint Broker)

+44 (0)20 7397 8900

Canaccord Genuity Limited

Simon Bridges, Emma Gabriel (Joint Broker)

 

Buchanan

Bobby Morse, Chris Lane, Stephanie Watson

www.buchanan.uk.com

+44 (0)20 7523 8000

 

 

+44 (0)20 7466 5000

 

 

About Mercia Technologies PLC

Mercia is a national investment group focused on the funding and scaling of innovative technology businesses with high growth potential from the UK regions. Mercia benefits from 19 university partnerships and offices across the Midlands, the North of England and Scotland providing it with access to high quality, regional deal flow. Mercia Technologies PLC is quoted on AIM with the epic "MERC".

Mercia's 'Complete Capital Solution' initially nurtures businesses via its third-party funds (now with circa £400million under management following recent mandate wins) and then over time Mercia can provide further funding to its 'Emerging Stars' by deploying direct investment follow-on capital from its own balance sheet. Since its IPO in December 2014, Mercia has invested over £63million directly across its portfolio of Emerging Stars.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHPGUQARUPRGQR
Date   Source Headline
3rd May 20249:44 amRNSTransaction in Own Shares
26th Apr 202410:00 amRNSTransaction in Own Shares
25th Apr 20249:29 amRNSTransaction in Own Shares
24th Apr 20249:41 amRNSTransaction in Own Shares
23rd Apr 20249:34 amRNSTransaction in Own Shares
22nd Apr 20249:43 amRNSTransaction in Own Shares
17th Apr 20249:23 amRNSTransaction in Own Shares
16th Apr 20249:44 amRNSTransaction in Own Shares
15th Apr 20249:12 amRNSTransaction in Own Shares
12th Apr 20249:43 amRNSTransaction in Own Shares
11th Apr 20249:35 amRNSTransaction in Own Shares
10th Apr 202411:34 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSYear end trading summary and date of results
9th Apr 20249:38 amRNSTransaction in Own Shares
5th Apr 20249:25 amRNSTransaction in Own Shares
4th Apr 20249:33 amRNSTransaction in Own Shares
3rd Apr 20249:22 amRNSTransaction in Own Shares
28th Mar 202411:41 amRNSTransaction in Own Shares
27th Mar 20249:57 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSGrant and variation of Options
26th Mar 202410:31 amRNSTransaction in Own Shares
25th Mar 202412:24 pmRNSTransaction in Own Shares
22nd Mar 20249:01 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSDirector/PDMR Dealings
21st Mar 20249:14 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSMercia secures two further BBB contracts
20th Mar 20249:32 amRNSTransaction in Own Shares
18th Mar 20249:59 amRNSTransaction in Own Shares
15th Mar 20249:04 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSMercia completes three syndicated funding rounds
13th Mar 202411:24 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSMercia's Northern VCTs raise £60.0million
12th Mar 20249:46 amRNSTransaction in Own Shares
11th Mar 20249:16 amRNSTransaction in Own Shares
8th Mar 202410:14 amRNSTransaction in Own Shares
7th Mar 202410:15 amRNSTransaction in Own Shares
5th Mar 202410:16 amRNSTransaction in Own Shares
4th Mar 20249:44 amRNSTransaction in Own Shares
1st Mar 202410:11 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSNew British Business Bank contracts
28th Feb 20248:38 amRNSTransaction in Own Shares
27th Feb 20248:44 amRNSTransaction in Own Shares
26th Feb 20248:49 amRNSTransaction in Own Shares
23rd Feb 20249:25 amRNSTransaction in Own Shares
21st Feb 20249:29 amRNSTransaction in Own Shares
16th Feb 20248:59 amRNSTransaction in Own Shares
15th Feb 20249:31 amRNSTransaction in Own Shares
9th Feb 20249:46 amRNSTransaction in Own Shares
8th Feb 20249:41 amRNSTransaction in Own Shares
7th Feb 20249:48 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.